The Effects of an Exercise Program in Leukemia Patients

被引:71
作者
Battaglini, Claudio L. [1 ,2 ]
Hackney, A. C. [1 ,3 ]
Garcia, Rey [2 ,4 ]
Groff, Diane [1 ]
Evans, Elizabeth [1 ]
Shea, Thomas [2 ,4 ]
机构
[1] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Appl Physiol Lab, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, UNC Hosp, Div Hematol Oncol, Chapel Hill, NC 27599 USA
关键词
cytokines; aerobic training; strength training; induction; myelogenous; neutropenia; RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER SURVIVORS; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; INTERVENTION; FATIGUE; HEALTH; WOMEN;
D O I
10.1177/1534735409334266
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose. To examine the feasibility of administering an in-hospital exercise program to acute leukemia patients undergoing chemotherapy. A secondary purpose explored the impact of exercise on selected physiological, psychological, and inflammatory markers. Methods. Ten patients, aged 18 to 50 years, diagnosed with acute leukemia or newly relapsed were assessed for body weight, height, body composition (skinfolds), cardiorespiratory endurance (total minutes on bicycle ergometer at 60% heart rate reserve), dynamic muscular endurance (Rocky Mountain Cancer Rehabilitation Institute protocol), fatigue (Revised Piper Fatigue Scale), depression (Center for Epidemiologic Studies Depression scale, National Institute of Mental Health questionnaire), and quality of life (Functional Assessment of Cancer Therapy-General) at baseline (within 3 days of diagnosis) and at the end of induction phase of treatment. Blood draws were taken at baseline, midpoint, and at the end of induction for analyses of inflammatory markers (Linco Luminex assay). Combined aerobic and strength training exercises were administered 3 times per week, twice daily, for 30 minutes. Paired-samples t-tests were used for the analyses of physiological and psychological parameters. One-way repeated measures analysis of variance seas used for the analyses of inflammatory markers. Results. Significant improvements in cardiorespiratory endurance (P = .009, baseline 8.9 +/- 8.8 minutes, postexercise intervention 17 +/- 14.3 minutes) with significant reductions in total fatigue scores (P = .009, baseline 4.6 +/- 1.7, postexercise intervention 1.8 +/- 1.6) and depression scores (P = .023, baseline 19 +/- 11.5, postexercise intervention 12 +/- 8.2) were observed. Marginally significant decrease in interletrkin-6 (IL-6; P = .059) with no significant changes in IL-10 (P = .223) or interferon-gamma (P = .882) were observed. Conclusion. Administration of exercise to acute leukemia patients undergoing treatment is feasible. The exercise protocol used increased cardiovascular endurance, reduced fatigue and depression scores, and maintained quality of life. Although no significant change in inflammation was observed, a trend demonstrating a reduction in IL-6 and an increase in IL-10 warrants further investigation.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 39 条
[1]
al-Majid S, 2001, Biol Res Nurs, V2, P186, DOI 10.1177/109980040100200304
[2]
American Cancer Society, Cancer Facts & Figures
[3]
[Anonymous], 2006, ACSMS GUIDELINES EXE, V7th, P63
[4]
[Anonymous], SEER stat fact sheets
[5]
[Anonymous], Facts and Statistics
[6]
Battaglini C.L., 2006, Medicina Sportiva, V10, P49
[7]
The effects of an individualized exercise intervention on body composition in breast cancer patients undergoing treatment [J].
Battaglini, Claudio ;
Bottaro, Martim ;
Dennehy, Carolyn ;
Rae, Logan ;
Shields, Edgar ;
Kirk, David ;
Hackney, Anthony .
SAO PAULO MEDICAL JOURNAL, 2007, 125 (01) :22-28
[8]
PSYCHOPHYSICAL BASES OF PERCEIVED EXERTION [J].
BORG, GAV .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1982, 14 (05) :377-381
[9]
BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195
[10]
THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579